Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2012; 18(13): 1517-1524
Published online Apr 7, 2012. doi: 10.3748/wjg.v18.i13.1517
Published online Apr 7, 2012. doi: 10.3748/wjg.v18.i13.1517
Figure 2 Change in dysmotility-like dyspepsia symptom score over time.
Significantly greater improvement was seen in dysmotility-like dyspepsia symptom score on day 28 of treatment in the proton pump inhibitor (PPI) group than in the H2-receptor antagonist (H2RA) + prokinetic (Prok) group. No significant additional symptomatic improvement was seen after day 7 of H2RA + Prok treatment, whereas further symptomatic improvements were seen over time in the PPI group. aP < 0.05, PPI vs H2RA + Prok; cP < 0.05 vs pre-Rx in each group; eP < 0.05 vs 7 d Rx in each group.
- Citation: Sakaguchi M, Takao M, Ohyama Y, Oka H, Yamashita H, Fukuchi T, Ashida K, Murotani M, Murotani M, Majima K, Morikawa H, Hashimoto T, Kiyota K, Esaki H, Amemoto K, Isowa G, Takao F. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia. World J Gastroenterol 2012; 18(13): 1517-1524
- URL: https://www.wjgnet.com/1007-9327/full/v18/i13/1517.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i13.1517